SHARE:  

Wednesday, June 26, 2024

12:00PM-1:00PM

In person or Via Zoom

https://partners.zoom.us/j/5823462701

*Participant Instructions

Lysomal functions of progranulin and therapeutic approaches for GRN-associated frontotemporal dementia

Gilbert Di Paolo, Ph.D.  

Distinguished Scientist and Executive Director

Discovery Biology

Denali Therapeutics, Inc.




Dr. Gil Di Paolo received a Ph.D. in Biology from the University of Lausanne in 1998, studying the role of microtubule regulators, stathmin and SCG10/Stathmin-2, in neuronal differentiation and survival in the lab of Dr. Gabriele Grenningloh at the Glaxo Institute for Molecular Medicine in Geneva. Gil subsequently conducted his postdoctoral studies at Yale University in the lab of Dr. Pietro De Camilli, where he discovered novel roles for phosphoinositide signaling in regulation of clathrin-mediated endocytosis and synaptic vesicle trafficking at mammalian synapses. In 2005, he obtained a Faculty appointment at Columbia University Medical Center and at the Taub Institute for Research on Alzheimer’s Disease and The Aging Brain, where he revealed a role for phosphoinositide and phospholipase signaling in the synaptotoxic actions of  Ab and autophagy. He then moved to Denali Therapeutics Inc. in 2016 to pursue his translational research on the role of lipid and immunometabolism dysregulation as well as endolysosomal dysfunction in neurodegenerative disorders. His team discovered a role of TREM2 and APOE in cholesterol metabolism and inflammation. They co-developed a brain-penetrant agonist clinical candidate antibody to TREM2 (DNL919) to enhance microglial functions in AD, identified novel lysosomal functions for progranulin and co-developed a brain penetrant progranulin biotherapeutic (DNL593) for GRN-associated frontotemporal dementia, which is currently in clinical development.


Join in person in the Marshall Wolf Conference Center or via Zoom https://partners.zoom.us/j/5823462701



Steps to claim CME credits for BWH Neurology Grand Rounds:

Send code to 1-857-214-2277.


*The code will be released when it is made available.

For more information about BWH Neurology Grand Rounds 2023-2024 click here

If you have any questions about the process for receiving CME credit, please contact the MGB Office of Continuing Professional Development (CPD) at PartnersCPD@partners.org or visit their website here.


Recordings of past seminars


July 3, 2024

There are no BWH Neurology Grand Rounds on July 3, 2024.

 

July 10, 2024

Marc Triola, M.D.

Bytes to Bedside: Exploring the Impact of Artificial Intelligence on Medicine


For questions and to submit feedback, please contact Seminar Directors Tracy Young-Pearse, Ph.D. and William R. Renthal, M.D., Ph.D.

To subscribe to Neurology Grand Rounds distribution list please click here.